• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.05% Nasdaq Up 1.24%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    6.48 Apr 24, 4:00PM EDT
    |Pre-Market : 6.48 0.00 (0.00%) 9:23AM EDT - Nasdaq Real Time Price
    Prev Close:6.48
    Open:N/A
    Bid:6.25 x 2000
    Ask:6.82 x 3400
    1y Target Est:8.38
    Beta:2.78465
    Next Earnings Date: 4-May-17BCRX Earnings announcement
    Day's Range:N/A - N/A
    52wk Range:2.49 - 9.25
    Volume:0
    Avg Vol (3m):1,726,120
    Market Cap:520.85M
    P/E (ttm):N/A
    EPS (ttm):-0.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BCRX

    Comparison

    Symbol% ChgMkt Cap
    BCRX 0.00%520.85M
    1N/A
    GSK97.85B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :-0.68
    Quarterly EPS Est (Mar-17) :-0.19
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback